Difference between revisions of "NCCN guidelines"
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
'''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.''' | '''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.''' | ||
| − | = | + | =Cancer Screening= |
[[Category:General reference pages]] | [[Category:General reference pages]] | ||
| + | *'''2018:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2018.0083 Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/30442736/ PubMed] | ||
| + | *'''2003:''' Authors not listed. [https://doi.org/10.6004/Jnccn.2003.0023 Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/19768883/ PubMed] | ||
| − | + | =Cancer Risk Reduction= | |
*'''2015:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2015.0105 Breast Cancer Risk Reduction, Version 2.2015.] [https://pubmed.ncbi.nlm.nih.gov/26150582/ PubMed] | *'''2015:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2015.0105 Breast Cancer Risk Reduction, Version 2.2015.] [https://pubmed.ncbi.nlm.nih.gov/26150582/ PubMed] | ||
| − | *'''2003:''' | + | *'''2003:''' Authors not listed. [https://doi.org/10.6004/Jnccn.2003.0026 Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/19768886/ PubMed] |
| − | |||
=Middle East and North Africa= | =Middle East and North Africa= | ||
Revision as of 19:43, 30 November 2023
This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page.
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.
Cancer Screening
- 2018: Bevers et al. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. PubMed
- 2003: Authors not listed. Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology. PubMed
Cancer Risk Reduction
- 2015: Bevers et al. Breast Cancer Risk Reduction, Version 2.2015. PubMed
- 2003: Authors not listed. Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology. PubMed
Middle East and North Africa
- 2010: Abulkhair et al. Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. PubMed
- 2010: Içli et al. Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region. PubMed
- 2010: Yusuf et al. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region. PubMed
- 2010: Bazarbachi et al. Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region. PubMed
- 2010: Jazieh et al. Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region. PubMed
- 2010: Shamieh et al. Modification and implementation of NCCN Guidelines on palliative care in the Middle East and North Africa region. PubMed
- 2010: Hassen et al. Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region. PubMed
Myeloid Growth Factor
- 2013: Crawford et al. Myeloid growth factors. PubMed
- 2011: Crawford et al. Myeloid growth factors. PubMed
- 2009: Crawford et al. Myeloid growth factors. PubMed
- 2007: Crawford et al. Myeloid growth factors. Clinical practice guidelines in oncology. PubMed
- 2005: Crawford et al. Myeloid growth factors clinical practice guidelines in oncology. PubMed
Fatigue
- 2010: Berger et al. NCCN Clinical Practice Guidelines Cancer-related fatigue. PubMed